PT  - JOURNAL ARTICLE
AU  - Rahmandad, Hazhir
AU  - Lim, Tse Yang
AU  - Sterman, John
TI  - Behavioral dynamics of COVID-19: estimating under-reporting, multiple waves, and adherence fatigue across 92 nations
AID  - 10.1101/2020.06.24.20139451
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.06.24.20139451
4099  - http://medrxiv.org/content/early/2021/01/18/2020.06.24.20139451.short
4100  - http://medrxiv.org/content/early/2021/01/18/2020.06.24.20139451.full
AB  - Effective responses to the COVID-19 pandemic require integrating behavioral factors such as risk-driven contact reduction, improved treatment, and adherence fatigue with asymptomatic transmission, disease acuity, and hospital capacity. We build one such model and estimate it for all 92 nations with reliable testing data. Cumulative cases and deaths through 22 December 2020 are estimated to be 7.03 and 1.44 times official reports, yielding an infection fatality rate (IFR) of 0.51% which has been declining over time. Absent adherence fatigue cumulative cases would have been 47% lower. Scenarios through June 2021 show that modest improvement in responsiveness could reduce cases and deaths ≈14%, more than the impact of vaccinating half of the population by that date. Variations in responsiveness to risk explain two orders of magnitude difference in per-capita deaths despite reproduction numbers fluctuating ∼ 1 across nations. A public online simulator facilitates scenario analysis over the coming months.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was used to conduct this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, codes, and simulation models are publicly available. https://github.com/tseyanglim/CovidGlobal